PMC:7796052 / 14521-14753
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"Antagonism of raloxifene was measured as a percent inhibition of specific binding of [3H]-bradykinin as control, obtained in the presence of raloxifene at 20 µM and using as reference compounds desArg10-KD for B1 and NPC-567 for B2.","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"357","span":{"begin":90,"end":100},"obj":"Gene"},{"id":"366","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"367","span":{"begin":86,"end":88},"obj":"Chemical"},{"id":"368","span":{"begin":141,"end":151},"obj":"Chemical"}],"attributes":[{"id":"A357","pred":"tao:has_database_id","subj":"357","obj":"Gene:3827"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D020849"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"MESH:D014316"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"MESH:D020849"},{"subj":"357","pred":"source","obj":"LitCovid-PubTator"},{"subj":"366","pred":"source","obj":"LitCovid-PubTator"},{"subj":"367","pred":"source","obj":"LitCovid-PubTator"},{"subj":"368","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T98","span":{"begin":0,"end":232},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T98","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93b2ec","default":true},{"id":"LitCovid-sentences","color":"#ccec93"}]}]}}